Literature DB >> 9803000

Renal lesions in Von Hippel-Lindau disease: the benign, the malignant, the unknown.

F Salomé1, P Colombeau, V Fermeaux, P Cazaux, J P Dumas, P Pfeifer, J J Moreau, S Richard, F Labrousse.   

Abstract

OBJECTIVES: To describe the features and treatment of renal lesions in von Hippel-Lindau disease (VHL) from a series of patients, to highlight important issues in the management of these lesions.
MATERIALS AND METHODS: We performed a retrospective study in 7 patients with VHL who underwent surgery for renal lesions between January 1990 and July 1996. The initial evaluation consisted of an abdominal CT scan and renal arteriography.
RESULTS: The mean age of patients at the time of discovery was 38 (+/- 12.01 years). All cases were of type 1. Radiology assessment underestimated the gravity of the lesions in 5 patients. In all patients, unilateral surgery was performed with the kidney being conserved in 4 cases. Of the 44 lesions removed, 23 had signs of progressiveness (atypical or malignant cyst, renal cell carcinoma), most of the cancers were of low grade. 84% of the lesions did not exceed 3 cm and 48% were </=1 cm. During follow-up (42 months), 2 patients relapsed.
CONCLUSION: The clinical and pathological features of renal lesions in VHL require strict and early follow-up (from the age of 15). Only under these circumstances should primary conservative surgery be performed, however, recurrences are frequent. This conservative approach remains to be validated by multicentric prospective studies.

Entities:  

Mesh:

Year:  1998        PMID: 9803000     DOI: 10.1159/000019771

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  2 in total

1.  Cerebellar hemangioblastoma in a patient with von hippel-lindau disease : a case report.

Authors:  D Abd Hamid; J Abdullah; A Ariff; M Muhamad; M Madhavan
Journal:  Malays J Med Sci       Date:  2000-07

2.  Von Hippel-Lindau disease: an evaluation of natural history and functional disability.

Authors:  Alberto Feletti; Mariagiulia Anglani; Bruno Scarpa; Francesca Schiavi; Francesca Boaretto; Stefania Zovato; Elisa Taschin; Mario Gardi; Elisabetta Zanoletti; Stefano Piermarocchi; Alessandra Murgia; Giacomo Pavesi; Giuseppe Opocher
Journal:  Neuro Oncol       Date:  2016-01-12       Impact factor: 12.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.